
The GPhA and its Biosimilars Council expressed concern about the new proposed value-based reimbursement rules for Part B medications.

The GPhA and its Biosimilars Council expressed concern about the new proposed value-based reimbursement rules for Part B medications.

Phase I clinical trials of PfSPZ revealed it may protect healthy adults, who have not been exposed to Malaria before, for more than on year.

FUJIFILM Diosynth Biotechnologies Opens New Laboratory Facility in Research Triangle Park, NC.

The Cell and Gene Therapy Catapult released a review of their third annual survey of GMP cell and gene therapy facilities in the United Kingdom.

CPhI China is expected to bring together approximately 35,000 attendees from more than 120 countries worldwide.

Under the terms of an agreement with Pfizer, WAVE will advance up to five programs from discovery through the selection of clinical candidates.

ANSM lifted the suspension on Catalent’s Beinheim, France facility, allowing the company to resume pharmaceutical operations.

MilliporeSigma expands its Carlsbad, California-based GMP capacity for viral and gene-therapy products by nearly 90%.

The company’s Aramus bags are made of an innovative material that is unlike that of the material currently used in commercial single-use bags.

A federal judge entered an order of permanent injunction against Paul W. Franck, the owner and operator of several compounding pharmacies in Florida.

The companies have agreed to an all-stock merger of equals transaction anticipated to close in the second half of 2016.

The collaborations have the goal of creating new tools that will help predict how people with Type 2 diabetes adhere to their medication.

Safe handling of HPAPIs requires determining exposure potential and selecting appro-priate containment strategies.

Experts discuss some of the emerging trends in bioprocessing in 2016, including 4D bioprinting, 2D-NMR, and the CAR-T design space.

Siegfried Schmitt, Principal Consultant, PAREXEL International, discusses how to report quality metrics to FDA.

Policies for patient access to life-saving therapies must keep pace with biomedical innovation.

MilliporeSigma, the North American life-sciences business of Germany’s Merck KGaA, added a 2000-L single-use bioreactor to its facility in Massachusetts.

EMD Serono, the North American biopharmaceutical business of Germany’s Merck KGaA, will expand its R&D facility in Massachusetts, US.

Pharmaceutical Technology Europe
Pharma understands the importance of patient centricity, but the problem is the gap between intent and action.

The agency found no differences in risk of pneumonia for different products.

The agency extends the indication of the drug in combination with bendamustine.

The agency recommends the approval of Zavicefta to treat infections caused by resistant bacteria.

PTSM: Pharmaceutical Technology Sourcing and Management
Hacene Mekerri will serve as vice-president of PPD’s central laboratory organization.

PTSM: Pharmaceutical Technology Sourcing and Management
Air Cargo Community Frankfurt takes steps to make Frankfurt Europe’s largest certified pharmaceutical hub.

PTSM: Pharmaceutical Technology Sourcing and Management
Quotient Clinical has expanded its clinical spray drying capability through the acquisition of a Niro Mobile Minor Spray Dryer.

PTSM: Pharmaceutical Technology Sourcing and Management
Worthington’s CryoScience by Taylor Wharton business will design and manufacture biostorage and logistics equipment for use in Cryoport’s life-sciences cryogenic logistics solutions.

PTSM: Pharmaceutical Technology Sourcing and Management
Platinum Press provides serialization-ready printed materials to apply final track-and-trace data onto packaged pharmaceutical products.

PTSM: Pharmaceutical Technology Sourcing and Management
Almac partnered with Optel Vision to provide a line-level solution (hardware and software) integrated with Almac’s proprietary level three, site-level software.

Immuno-oncology drugs are demonstrating patient benefits, but growing resistance to the high cost has implications for patients, market access, and manufacturers.

The agency holds a workshop to strengthen collaboration with healthcare providers.